152 results
Page 5 of 8
8-K
EX-99.1
a867uk
12 Nov 19
Results of Operations and Financial Condition
8:40am
8-K
EX-99.1
700xprq1myhjgpay
28 Oct 19
Heron Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for HTX-011 for Management of Postoperative Pain
8:41am
8-K
EX-99.1
731jofj9 6neeai96q
22 Oct 19
Other Events
8:42am
424B2
3k7cj pisg
7 Oct 19
Prospectus for primary offering
4:28pm
424B5
f6on7d0h bhlk
3 Oct 19
Prospectus supplement for primary offering
4:03pm
8-K
EX-99.1
f4facgejr75kv6 kr
2 Oct 19
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty
7:57am
8-K
EX-99.2
0eqyan4j2g7
2 Oct 19
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty
7:57am
8-K
EX-99.1
73h072a
1 Oct 19
Heron Therapeutics Appoints Kimberly Manhard to Board of Directors
4:25pm
8-K
EX-99.1
p2yh 5wzr5jkwil7qo50
1 Oct 19
Heron Therapeutics Appoints Stephen Davis to Board of Directors
4:16pm
8-K
EX-99.1
n7yn31eba9
1 Oct 19
Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Management of Postoperative Pain
8:42am
8-K
EX-99.1
290iga 2o6bs
20 Aug 19
Heron Therapeutics Announces Publication of Results from EPOCH 2, a Phase 3 Study of HTX-011 in Patients Undergoing Hernia Repair Surgery
8:35am
8-K
EX-99.1
lecw mjos21
5 Aug 19
Results of Operations and Financial Condition
8:40am
8-K
EX-99.1
yyomdnsnj
21 May 19
Heron Therapeutics Announces Publication of Results from Phase 3 EPOCH 1 Study ofHTX-011 in Patients Undergoing Bunionectomy
9:15am
8-K
EX-99.1
f7ugl64
14 May 19
Heron Therapeutics Presents New Results from Real-world Study Showing
8:35am
8-K
EX-99.1
gsckjlecnekb21qaw
9 May 19
Results of Operations and Financial Condition
8:35am
8-K
EX-99.1
lkjfnz
1 May 19
Heron Therapeutics Receives Complete Response Letter FORHTX-011 for the Management of Postoperative Pain
8:06am